> top > docs > PMC:7205724 > spans > 94-274 > annotations

PMC:7205724 / 94-274 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 158-165 Species denotes patient Tax:9606

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 38-53 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 59-74 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T3 127-142 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T1 38-53 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulins http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 59-74 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T2 127-142 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T3 21-74 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 76-86 Sentence denotes Highlights
T5 87-175 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
3 158-165 Species denotes patient Tax:9606

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T15 13-19 NNS denotes agents
T16 19-20 -COLON- denotes :
T17 21-36 NNS denotes Anti-antibodies
T18 36-37 -COMMA- denotes ,
T19 38-53 NNS denotes immunoglobulins
T20 53-54 -COMMA- denotes ,
T21 55-58 CC denotes and
T22 59-74 NNS denotes corticosteroids
T23 76-86 NNS denotes Highlights
T24 87-88 IN denotes •
T25 90-94 NNP denotes IVIG
T26 94-95 -COMMA- denotes ,
T27 96-104 VBN denotes combined
T28 105-109 IN denotes with
T29 110-123 NN denotes moderate-dose
T30 124-126 IN denotes of
T31 127-142 NNS denotes corticosteroids
T32 142-143 -COMMA- denotes ,
T33 144-149 MD denotes might
T34 150-157 VB denotes improve
T35 158-165 NN denotes patient
T36 166-174 NNS denotes outcomes
T37 176-177 PDT denotes •
R15 T17 T18 arg1Of Anti-antibodies,","
R16 T19 T18 arg2Of immunoglobulins,","
R17 T21 T20 arg1Of and,","
R18 T18 T21 arg1Of ",",and
R19 T22 T21 arg2Of corticosteroids,and
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R28 T25 T33 arg1Of IVIG,might
R29 T34 T33 arg2Of improve,might
R30 T25 T34 arg1Of IVIG,improve
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 38-53 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 21-74 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 76-86 Sentence denotes Highlights
T5 87-175 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.